• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Cidara Therap(CDTX.US)

Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov25
Cidara Therapeutics Achieves Patient Enrollment Goal for ANCHOR Trial
10:06
Nov24
Merck & Co. Acquires Cidara Therapeutics for $9.2 Billion
03:52
Nov17
Merck Expects Over $5 Billion in Revenue from Cidara's Flu Drug
13:32
Merck Executives Indicate Cidara's Drug Can Go To Market Without CDC Approval
13:24
Nov15
Merck to Acquire Cidara Therapeutics for $9.2 Billion
10:58
Nov14
H.C. Wainwright analyst downgrades Cidara Therapeutics to hold
15:53

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -83.23 M, EPS -3.0961

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -25.72 M, EPS -1.6541

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -23.48 M, EPS -1.6561

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
10.470
+155.37%
+6.250
ANGH
3.870
+66.81%
+1.555
ESHA
22.250
+54.73%
+7.870
SIDU
3.980
+49.06%
+1.315
NCL
0.2787
+43.66%
+0.085
RDACR
0.2493
+31.21%
+0.059
ESHAR
0.2216
+30.35%
+0.052
VNDA
8.915
+26.82%
+1.885
ORIS
1.540
+26.23%
+0.320
ULY
3.460
+25.36%
+0.700
View More